The use of combination FEIBA and rFVIIa bypassing therapy, with TEG profiling, in uncontrollable bleeding associated with acquired haemophilia A

Haemophilia

Volumn 15, Issue 3, 2009, Pages 828-830

  Dunkley, Scott M ^a   Yang, K ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; IMMUNOGLOBULIN; PREDNISONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RITUXIMAB;

ADULT; ANEMIA; ANOREXIA; BLEEDING; BLOOD SAMPLING; CASE REPORT; COMPARTMENT SYNDROME; DISEASE CONTROL; DISEASE RESISTANCE; DISEASE SEVERITY; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG USE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOPHILIA A; HEMOSTASIS; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LETTER; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; RECURRENT DISEASE; SKIN BRUISING; SURGICAL WOUND; THROMBOELASTOGRAPHY;

ADULT; ANOREXIA; BLOOD COAGULATION FACTORS; DRUG THERAPY, COMBINATION; FACTOR VIIA; FEMALE; HEMOPHILIA A; HEMOSTASIS; HUMANS; POSTOPERATIVE HEMORRHAGE; RECOMBINANT PROTEINS;

EID: 65449179494     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01927.x     Document Type: Letter

References (5)

1. Borg J, Levesque H. Epidemiology and one-year outcomes in patients with acquired haemophilia A in France: The SACHA prospective study. J Thromb Haemost 2007; 5(Suppl. 2): O-M-062.
2. Schneiderman J, Nugent DJ, Young G. Sequential therapy with activated prothrombin complex concentrate and recombinant factor VIIa in patients with severe haemophilia and inhibitors. Haemophilia 2004; 10: 347-51.
3. Shima M, Matsumoto T, Ogiwara K. New assays for monitoring haemophilia treatment. Haemophilia 2008; 14: 83-92.
4. Hayashi T, Tanaka I, Shima M et al. Unresponsiveness to factor VIII inhibitor bypassing agents during haemostatic treatment for life-threatening massive bleeding in a patient with haemophilia A and a high responding inhibitor. Haemophilia 2004, 10: 397-400.
5. Isbister J, Phillips L, Dunkley S, Jankelowitz G, McNeil J, Cameron P. Recombinant activated factor VII in critical bleeding: Experience from the Australian and New Zealand Haemostasis Register. Intern Med J 2008; 38: 156-65.